Cytoreductive surgery following neoadjuvant chemotherapy in patients with initial unresectable stage IV ovarian cancer

被引：0
|
作者：
Hogen, Liat [1 ]
Tanen, Adina [2 ]
May, Taymaa [1 ]
Avery, Lisa [3 ]
Ferguson, Sarah [1 ]
Laframboise, Stephane [1 ]
Bouchard-Fortier, Genevieve [1 ]
Bernardini, Marcus [1 ]
机构：
[1] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Temerty Sch Med, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1198
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience
    Ahmet Bilici
    Taflan Salepci
    Faysal Dane
    Mahmut Gumus
    Bala Basak Oven Ustaalioglu
    Mesut Seker
    Tarik Salman
    Cem Turan
    Orhan Unal
    Mustafa Yaylaci
    Archives of Gynecology and Obstetrics, 2010, 282 : 417 - 425
  • [2] Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience
    Bilici, Ahmet
    Salepci, Taflan
    Dane, Faysal
    Gumus, Mahmut
    Ustaalioglu, Bala Basak Oven
    Seker, Mesut
    Salman, Tarik
    Turan, Cem
    Unal, Orhan
    Yaylaci, Mustafa
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2010, 282 (04) : 417 - 425
  • [3] Clinical assessment of neoadjuvant chemotherapy and interval cytoreductive surgery for unresectable advanced ovarian cancer
    Ushijima, K
    Ota, S
    Komai, K
    Matsuo, G
    Motoshima, S
    Honda, S
    Tomonari, R
    Sugiyama, T
    Kamura, T
    INTERNATIONAL SURGERY, 2002, 87 (03) : 185 - 190
  • [4] Should patients with ovarian cancer receive intraperitoneal chemotherapy following initial cytoreductive surgery?
    Carolyn Runowicz
    Nature Clinical Practice Oncology, 2006, 3 : 416 - 417
  • [5] Should patients with ovarian cancer receive intraperitoneal chemotherapy following initial cytoreductive surgery?
    Runowicz, Carolyn
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (08): : 416 - 417
  • [6] Neoadjuvant chemotherapy and cytoreductive surgery in epithelial ovarian cancer
    Siriwan Tangjitgamol
    Jitti Hanprasertpong
    Marta Cubelli
    Claudio Zamagni
    World Journal of Obstetrics and Gynecology, 2013, (04) : 153 - 166
  • [7] Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
    Vergote, Ignace
    Trope, Claes G.
    Amant, Frederic
    Kristensen, Gunnar B.
    Ehlen, Tom
    Johnson, Nick
    Verheijen, Rene H. M.
    van der Burg, Maria E. L.
    Lacave, Angel J.
    Panici, Pierluigi Benedetti
    Kenter, Gemma G.
    Casado, Antonio
    Mendiola, Cesar
    Coens, Corneel
    Verleye, Leen
    Stuart, Gavin C. E.
    Pecorelli, Sergio
    Reed, Nick S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10): : 943 - 953
  • [8] Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase
    Tran, Arthur-Quan
    Erim, Daniel O.
    Sullivan, Stephanie A.
    Cole, Ashley L.
    Barber, Emma L.
    Kim, Kenneth H.
    Gehrig, Paola A.
    Wheeler, Stephanie B.
    GYNECOLOGIC ONCOLOGY, 2018, 148 (02) : 329 - 335
  • [9] Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
    Mazzeo, F
    Berlière, M
    Kerger, J
    Squifflet, J
    Duck, L
    D'Hondt, V
    Humblet, Y
    Donnez, J
    Machiels, JP
    GYNECOLOGIC ONCOLOGY, 2003, 90 (01) : 163 - 169
  • [10] Correct timing of cytoreductive surgery and chemotherapy in ovarian cancer: Neoadjuvant chemotherapy
    Pignata, S
    Tambaro, R
    TUMORI JOURNAL, 2003, : S37 - S37
12345